Metraipolis › archive › dc_fa27da6cc86f
KRAS G12C inhibition enhances efficacy to conventional chemotherapy in KRAS-mutant NSCLC — Europe PMC PMID:41001026
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41001026
- DOI
- 10.3389/fonc.2025.1654491
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-10T00:56:22.790Z
- SHA-256 of the archived text
9f4366e09f3ecd91c277bfc4e795015ebfb9ecc06b1c7212486db5df256f6829- Stable URL of this page
https://metraipolis.com/documento/dc_fa27da6cc86f
How to cite
KRAS G12C inhibition enhances efficacy to conventional chemotherapy in KRAS-mutant NSCLC — Europe PMC PMID:41001026 — Europe PMC (en), https://europepmc.org/article/MED/41001026 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_fa27da6cc86f (Metraipolis archive dc_fa27da6cc86f, sha256 9f4366e09f3ecd91c277bfc4e795015ebfb9ecc06b1c7212486db5df256f6829)
BibTeX
@misc{dcfa27da6cc86f,
title = {KRAS G12C inhibition enhances efficacy to conventional chemotherapy in KRAS-mutant NSCLC — Europe PMC PMID:41001026},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41001026},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_fa27da6cc86f; sha256 9f4366e09f3ecd91c277bfc4e795015ebfb9ecc06b1c7212486db5df256f6829},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41001026. Agents can read the archived copy with the MCP tool read_document.